FDA Inspection 569950 — Swedish Orphan Biovitrum AB (Publ)
The FDA completed an inspection of Swedish Orphan Biovitrum AB (Publ) on Jan 20, 2009 in Stockholm. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 20, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Stockholm (Sweden)